Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03982199
What this trial is testing

An Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Diseases
Janssen Vaccines & Prevention B.V. 5,815
Testing effectiveness (Phase 2)Looking for participantsNCT07762014
What this trial is testing

RBCG-N-RSV Vaccine in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection PreventionTuberculosis Prevention
Biothervax SpA 200
Early research (Phase 1)Study completedNCT03403348
What this trial is testing

A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants

Who this might be right for
Healthy
Janssen BioPharma, Inc. 130
Large-scale testing (Phase 3)Ended earlyNCT04980391
What this trial is testing

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 384
Not applicableNot Yet RecruitingNCT07346963
What this trial is testing

RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV

Who this might be right for
Respiratory Syncytial Virus InfectionAcute Bronchiolitis Due to Respiratory Syncytial VirusPneumonia+1 more
Eskisehir Osmangazi University 4,000
Testing effectiveness (Phase 2)Study completedNCT00232635
What this trial is testing

The Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT

Who this might be right for
Respiratory Syncytial Virus Infections
Arrow Therapeutics 27
Not applicableStudy completedNCT03728413
What this trial is testing

The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus

Who this might be right for
RSV Infection
Imperial College London 28
Not applicableActive Not RecruitingNCT07264478
What this trial is testing

Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China

Who this might be right for
RSV InfectionDisease Burden
Beijing Children's Hospital 1,100
Not applicableStudy completedNCT00111878
What this trial is testing

Study to Evaluate MEDI-534 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsParainfluenza Infections
MedImmune LLC 120
Large-scale testing (Phase 3)Study completedNCT02911935
What this trial is testing

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

Who this might be right for
Respiratory Syncytial Virus, Bronchiolitis
Washington University School of Medicine 200
Early research (Phase 1)Study completedNCT01562938
What this trial is testing

MEDI-557 Adult Dosing

Who this might be right for
Respiratory Syncytial Virus
MedImmune LLC 42
Not applicableActive Not RecruitingNCT06851806
What this trial is testing

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Virus (RSV)
AstraZeneca 21
Not applicableUnknownNCT02093715
What this trial is testing

FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma

Who this might be right for
Acute Bronchiolitis
Tel-Aviv Sourasky Medical Center 400
Large-scale testing (Phase 3)Study completedNCT05096208
What this trial is testing

Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age

Who this might be right for
RSV
Pfizer 1,028
Large-scale testing (Phase 3)Study completedNCT01006629
What this trial is testing

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Who this might be right for
Respiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more
Abbott 100
Not applicableUnknownNCT05928507
What this trial is testing

FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

Who this might be right for
Influenza AInfluenza Type BSARS CoV 2 Infection+1 more
Baebies, Inc. 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT07214571
What this trial is testing

S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Who this might be right for
Respiratory Syncytial Virus Infections
Shionogi 192
Large-scale testing (Phase 3)Study completedNCT05301322
What this trial is testing

Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
Pfizer 1,471
Early research (Phase 1)Study completedNCT04851977
What this trial is testing

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 60
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Next Page